Principal Investigator
Cynthia Levy
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230825
Clinical Trial Summary
An Open-Label, Long-Term Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants
with Erythropoietic Protoporphyria (EPP)
Phase
Other
Funding Agency/Sponsor
Industry
Disease
Erythropoietic protoporphyria (EPP)
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu